1 – 14 of 14
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Extended anticoagulation for venous thromboembolism : A survey of the American Venous Forum and the European Venous Forum
(
- Contribution to journal › Article
-
Mark
Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle-aged and older adults: A population-based cohort study
(
- Contribution to journal › Letter
- 2021
-
Mark
A simplified decision rule to rule out deep vein thrombosis using clinical assessment and D-dimer
(
- Contribution to journal › Article
-
Mark
Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism
(
- Contribution to journal › Article
- 2020
-
Mark
Genetic risk factors for venous thromboembolism
(
- Contribution to journal › Scientific review
-
Mark
Clinical pre-test probability adjusted versus age-adjusted D-dimer interpretation strategy for DVT diagnosis : A diagnostic individual patient data meta-analysis
(
- Contribution to journal › Article
- 2007
-
Mark
Thromboprophylaxis with dalteparin in medical patients: which patients benefit?
(
- Contribution to journal › Article
-
Mark
Monitoring fondaparinux with the Sonoclot
(
- Contribution to journal › Article
- 2005
-
Mark
Subcutaneous fat accumulation and BMI associated with risk for pulmonary embolism in patients with proximal deep vein thrombosis: a population study based on 23,796 consecutive autopsies
(
- Contribution to journal › Article
-
Mark
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients
(
- Contribution to journal › Article
- 2001
-
Mark
Development of a Method to Measure Plasma Levels of Activated Protein C in Complex with Protein C Inhibitor
2001)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism : Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls
(
- Contribution to journal › Article
- 1997
-
Mark
The factor VR5O6Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
(
- Contribution to journal › Article
-
Mark
Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls
(
- Contribution to journal › Article